Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Synageva BioPharma and Trimeris enter into merger agreement

June 16, 2011

Roche team synthesizes novel glycogen synthase activators

June 16, 2011

Novel acetyl-CoA carboxylase inhibitors prepared by Pfizer

June 16, 2011

Merck & Co. claims new hydroxycarboxylic acid HCA2 receptor agonists

June 16, 2011

Takeda presents new agents for treatment of diabetes

June 16, 2011

JDFR and Selecta Biosciences collaborate on vaccines for type 1 diabetes

June 15, 2011

Pasireotide reduces elevated urinary free cortisol in patients with Cushing's disease

June 15, 2011

French and German authorities suspend use of pioglitazone-containing products

June 14, 2011

Synthes and Eli Lilly sign agreement focused on osteoporosis and bone fractures

June 14, 2011

Metreleptin shows promise in partial lipodystrophy and amenorrhea

June 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...